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   The clinical effectiveness and safety of terodiline hydrochloride and clenbuterol hydrochloride 
were studied on 51 patients with neurogenic bladder, stress incontinence, unstable bladder and 
others, the chief complaints of which were urinary frequency or urinary incontinence. Overall 
improvement was graded as marked in 6 patients (11.8%), moderate in 20 patients (39.2%), 
slight in 11 patients (21.6%), unchanged in 13 patients (25.5%) and aggravated in one. The 
patients impression was "good" or better in 56.9%. 
   There were a total of 13 cases (25.5%) of adverse reactions, namely, 7 cases of finger tremor, 
3 cases of dry mouth and others. These reactions disappeared rapidly after the dicontinuance of 
drug administration. 
   The clinical efficacy in the treatment of subjective symptoms was 71.4% for urinary inconti-
nence, 56.4% for diurnal pollakisuria. The examination of lower urethral functions demonstrated 
a significant (p<0.01) increase in bladder capacity at first desire and maximum desire to void. 
However, we found no significant increase in urethral clossure pressure. 
   The findings of this study suggest that terodiline hydrochloride and clenbuterol hydrochloride 
are very useful for the treatment of urinary frequency and incontinence.
(Acta Urol. Jpn. 37: 1575-1580, 1991)









































































































































勝見,ほ か ・尿失禁 ・β2刺激剤
Table5.投与前後における膀胱内圧および尿道内圧
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最 大 膀 胱 容 量
(ml)
最 大 静 止 時 圧
(cmH20)












































項 ・ 例数(平 班,E)(平 叢 、E)
排 尿 量
(ml)







































意 に 高 か った(p<0.05)(Tablel1),
9)有 用 度
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